Last updated on May 2019

Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer


Find a site near you

Start Over

Arkhangelsk Clinical Oncology Center

Arkhangel'sk, Russian Federation
  Connect »